プロテオミクス市場：タイプ、オファリング、技術、用途、エンドユーザー別-2025～2030年世界予測

プロテオミクス市場は、2024年には352億4,000万米ドルとなり、2025年には396億9,000万米ドル、CAGR12.93%で成長し、2030年には731億2,000万米ドルに達すると予測されています。

急速に進化するプロテオミクスの領域では、技術革新と科学的ブレークスルーが研究に影響を与えるだけでなく、産業が生物学的分析にアプローチする方法を再定義しています。近年、プロテオミクス市場は、医療研究、農業、診断、創薬の進歩の礎石として台頭してきました。この変革は、正確な治療介入と革新的な製品開発への道を開く、タンパク質の機能と相互作用のより深い理解によって推進されています。現在の環境は、学際的アプローチと技術主導の発見の統合によって特徴づけられる、活気に満ちた競合環境です。利害関係者がこのような状況を乗り切る中で、より深い知見を引き出すために、従来の調査手法と新しい技術とのギャップを埋めることが重視されるようになってきています。

このエグゼクティブサマリーでは、プロテオミクス市場を包括的に調査し、新たな動向、技術の進歩、将来の成長を形作る上で重要な戦略的洞察について詳しく解説します。技術的視点とビジネス的視点の両方を確保することを念頭に、市場の促進要因・課題・機会をまとめています。全体的な解説は、プロテオミクスの変革的性質、その戦略的価値提案、先端研究と機器への投資がいかにサステイナブル成長を促進するかを、リーダーや意思決定者が理解できるように設計されています。

プロテオミクスを形成する変革的シフト

プロテオミクスの情勢は、産業のパラダイムを再定義し、イノベーションを加速させる変革期を迎えています。最新のブレークスルーは伝統的研究の枠組みを変え、古典的な手法から自動化、高スループット分析、統合データシステムを活用した先進的技術への移行を促しています。特に質量分析と先進的ソフトウェア分析における技術の進歩は、利用可能な洞察のレベルを深め、研究者が複雑なタンパク質相互作用や経路をかつてないほど明瞭に解読することを可能にしています。

デジタルトランスフォーメーションと人工知能の導入は、プロテオミクスの能力をさらに向上させ、正確さとスピードを促進するリアルタイム分析と予測的洞察を可能にしています。このようなシフトは、ラボだけの問題ではなく、サプライチェーンの力学、製品開発サイクル、戦略的な投資決定にも影響を及ぼしています。市場参入企業は、進化し続ける世界市場で競合を維持するために、ますます特殊な機器や試薬を採用し、研究投資を最先端の技術インフラに合わせるようになっています。革新的な研究手法と効率的なワークフローの融合により、再現性とコスト効率が継続的に改善されています。産業が成長を続ける中、こうした変革的なシフトは、品質、革新性、拡大性の新たなベンチマークを設定しつつあります。

さらに、規制の進化や品質基準の高まりにより、組織は長年のプラクティスを見直す必要に迫られています。最先端の分析手法と機能横断的なコラボレーションを統合することで、企業は新たな市場の需要を取り込み、競合を維持することができます。

多様化する市場における主要セグメンテーション洞察

包括的なセグメンテーション分析により、プロテオミクス市場の多層的な見方が明らかになり、その複雑さと幅広さが浮き彫りになりました。まず、プロテオミクス市場をタイプ別に見ると、発現プロテオミクス、機能プロテオミクス、構造プロテオミクスに分類され、それぞれがタンパク質の挙動や相互作用に関する微妙な洞察を提供しています。この分類により、利害関係者は特定のタンパク質機能と研究要件に基づいてアプローチを調整することができます。さらに、消耗品、機器・装置、試薬・キット、サービス、ソフトウエアの各セグメントを詳細に調査することで、サンプル調製や分析からデータ解釈に至るまで、プロテオミクスワークフローに不可欠なすべてのコンポーネントが網羅されていることを確認しています。

さらに、技術的セグメンテーションでは、市場をクロマトグラフィー、電気泳動、質量分析、タンパク質マイクロアレイ、X線結晶学に分類することで、複雑な図を描いています。クロマトグラフィーの領域では、ガスクロマトグラフィーと高速液体クロマトグラフィー（HPLC）にさらに分類することで、分離科学における進化する手法を浮き彫りにしています。同様に、電気泳動はキャピラリー電気泳動とゲル電気泳動に細分化され、タンパク質分離技術の精度と拡大性の進歩を反映しています。この多角的なセグメンテーションはさらに、農業・食品安全、バイオテクノロジー、臨床診断、創薬をカバーするアプリケーションベースの調査によって補完され、これによって研究が実際の産業アプリケーションにリンクされます。

最後に、エンドユーザー別セグメンテーションは、学術研究機関、契約研究機関、病院・診断ラボ、製薬・バイオテクノロジー企業における市場需要に関する鋭い洞察を記載しています。このきめ細かなセグメンテーションは、プロテオミクス市場が多様なニーズと運用フレームワークの影響を受けているという事実を強調し、戦略的意思決定者が独自の運用要件とエンドユーザーの期待に沿ったソリューションをカスタマイズできるようにしています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 創薬とバイオマーカー調査への投資増加がプロテオミクスを後押し
    • 質量分析とAIの進歩によりタンパク質分析の精度が向上
    • 個別化医療に対する需要の高まりがプロテオミクス市場の成長を促進
  • 抑制要因
    • 新興市場におけるプロテオミクス技術への高コストとアクセス制限
  • 機会
    • 臨床診断と精密医療におけるプロテオミクス用途の拡大
    • プロテオミクス：早期疾患検出と標的治療の進歩
  • 課題
    • プロテオミクス技術に関する複雑な規制基準を世界規模で理解する
• 市場セグメンテーション分析
  • タイプ：構造プロテオミクスは、タンパク質複合体と立体構造の詳細な三次元マッピングを記載
  • 用途：進行中の創薬により、世界中でプロテオミクスの需要が高まっている
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 プロテオミクス市場：タイプ別

• イントロダクション
• 表現プロテオミクス
• 機能プロテオミクス
• 構造プロテオミクス

第7章 プロテオミクス市場：オファリング別

• イントロダクション
• 消耗品
• 機器と設備
• 試薬とキット
• サービス
• ソフトウェア

第8章 プロテオミクス市場：技術別

• イントロダクション
• クロマトグラフィー
  • ガスクロマトグラフィー
  • 高速液体クロマトグラフィー（HPLC）
• 電気泳動
  • キャピラリー電気泳動
  • ゲル電気泳動
• 質量分析
• タンパク質マイクロアレイ
• X線結晶構造分析

第9章 プロテオミクス市場：用途別

• イントロダクション
• 農業と食品安全
• バイオテクノロジー
• 臨床診断
• 創薬

第10章 プロテオミクス市場：エンドユーザー別

• イントロダクション
• 学術研究機関
• 契約研究機関
• 病院と診断ラボ
• 製薬・バイオテクノロジー企業

第11章 南北アメリカのプロテオミクス市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋のプロテオミクス市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのプロテオミクス市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析、2024年
• FPNVポジショニングマトリックス、2024年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Alphalyse A/S
• Applied Biomics, Inc.
• BGI Group
• Bio-Rad Laboratories, Inc.
• Biogenity ApS
• Biognosys AG
• Bruker Corporation
• CD Genomics
• CovalX AG
• Creative Proteomics
• Danaher Corporation
• Eurofins EAG Materials Sciences LLC
• Evosep ApS
• Illumina, Inc.
• JPT Peptide Technologies GmbH
• Merck KGaA
• Meta Biosciences Pvt Ltd.
• Metware BIoTechnology Inc.
• MS Bioworks LLC
• OmicScouts GmbH
• PerkinElmer Inc.
• PolyQuant GmbH
• Proteome Factory AG
• Proteomics International Pty Ltd.
• Rapid Novor Inc.
• Thermo Fisher Scientific Inc
• VProteomics
• Waters Corporation

LIST OF FIGURES

• FIGURE 1. PROTEOMICS MARKET MULTI-CURRENCY
• FIGURE 2. PROTEOMICS MARKET MULTI-LANGUAGE
• FIGURE 3. PROTEOMICS MARKET RESEARCH PROCESS
• FIGURE 4. PROTEOMICS MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL PROTEOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL PROTEOMICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL PROTEOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PROTEOMICS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL PROTEOMICS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PROTEOMICS MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL PROTEOMICS MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL PROTEOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL PROTEOMICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL PROTEOMICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL PROTEOMICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS PROTEOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS PROTEOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES PROTEOMICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES PROTEOMICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. PROTEOMICS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. PROTEOMICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. PROTEOMICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL PROTEOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PROTEOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PROTEOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PROTEOMICS MARKET DYNAMICS
• TABLE 7. GLOBAL PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PROTEOMICS MARKET SIZE, BY EXPRESSION PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PROTEOMICS MARKET SIZE, BY FUNCTIONAL PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PROTEOMICS MARKET SIZE, BY STRUCTURAL PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PROTEOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PROTEOMICS MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PROTEOMICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PROTEOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PROTEOMICS MARKET SIZE, BY SOFTWARES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PROTEOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PROTEOMICS MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC), BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PROTEOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PROTEOMICS MARKET SIZE, BY GEL ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PROTEOMICS MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PROTEOMICS MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PROTEOMICS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL PROTEOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL PROTEOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL PROTEOMICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL PROTEOMICS MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS PROTEOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. ARGENTINA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. BRAZIL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. CANADA PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. CANADA PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 63. CANADA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. CANADA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 65. CANADA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 66. CANADA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. CANADA PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. MEXICO PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES PROTEOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. AUSTRALIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. AUSTRALIA PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. CHINA PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. CHINA PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 100. CHINA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. CHINA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 102. CHINA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 103. CHINA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. CHINA PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. INDIA PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. INDIA PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 107. INDIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. INDIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 109. INDIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 110. INDIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. INDIA PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. INDONESIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 117. INDONESIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. INDONESIA PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. JAPAN PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 123. JAPAN PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 124. JAPAN PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. JAPAN PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. MALAYSIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 130. MALAYSIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 131. MALAYSIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. MALAYSIA PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. PHILIPPINES PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 137. PHILIPPINES PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 138. PHILIPPINES PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. PHILIPPINES PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. SINGAPORE PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 144. SINGAPORE PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 145. SINGAPORE PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. SINGAPORE PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. SOUTH KOREA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 151. SOUTH KOREA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 152. SOUTH KOREA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. SOUTH KOREA PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. TAIWAN PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 158. TAIWAN PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 159. TAIWAN PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. TAIWAN PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. THAILAND PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 165. THAILAND PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 166. THAILAND PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. THAILAND PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. VIETNAM PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 172. VIETNAM PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 173. VIETNAM PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. VIETNAM PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. DENMARK PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 187. DENMARK PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 188. DENMARK PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. DENMARK PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 193. EGYPT PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 194. EGYPT PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 195. EGYPT PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. EGYPT PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 200. FINLAND PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 201. FINLAND PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 202. FINLAND PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. FINLAND PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 207. FRANCE PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 208. FRANCE PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 209. FRANCE PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. FRANCE PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 214. GERMANY PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 215. GERMANY PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 216. GERMANY PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 217. GERMANY PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 221. ISRAEL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 222. ISRAEL PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 223. ISRAEL PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. ISRAEL PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. ITALY PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. ITALY PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 227. ITALY PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 228. ITALY PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 229. ITALY PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 230. ITALY PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. ITALY PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 235. NETHERLANDS PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 236. NETHERLANDS PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 237. NETHERLANDS PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. NETHERLANDS PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 242. NIGERIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 243. NIGERIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 244. NIGERIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 245. NIGERIA PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 249. NORWAY PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 250. NORWAY PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 251. NORWAY PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 252. NORWAY PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 253. POLAND PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 254. POLAND PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 255. POLAND PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 256. POLAND PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 257. POLAND PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 258. POLAND PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 259. POLAND PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 260. QATAR PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 261. QATAR PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 262. QATAR PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 263. QATAR PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 264. QATAR PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 265. QATAR PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 266. QATAR PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 270. RUSSIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 271. RUSSIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 272. RUSSIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 273. RUSSIA PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 277. SAUDI ARABIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 278. SAUDI ARABIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 279. SAUDI ARABIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 280. SAUDI ARABIA PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 284. SOUTH AFRICA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 285. SOUTH AFRICA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 286. SOUTH AFRICA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 287. SOUTH AFRICA PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 291. SPAIN PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 292. SPAIN PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 293. SPAIN PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 294. SPAIN PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 298. SWEDEN PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 299. SWEDEN PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 300. SWEDEN PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 301. SWEDEN PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 305. SWITZERLAND PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 306. SWITZERLAND PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 307. SWITZERLAND PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 308. SWITZERLAND PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 311. TURKEY PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 312. TURKEY PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 313. TURKEY PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 314. TURKEY PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 315. TURKEY PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 318. UNITED ARAB EMIRATES PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 319. UNITED ARAB EMIRATES PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 320. UNITED ARAB EMIRATES PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 321. UNITED ARAB EMIRATES PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 322. UNITED ARAB EMIRATES PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 323. UNITED KINGDOM PROTEOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 324. UNITED KINGDOM PROTEOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 325. UNITED KINGDOM PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 326. UNITED KINGDOM PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
• TABLE 327. UNITED KINGDOM PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
• TABLE 328. UNITED KINGDOM PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 329. UNITED KINGDOM PROTEOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 330. PROTEOMICS MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 331. PROTEOMICS MARKET, FPNV POSITIONING MATRIX, 2024

The Proteomics Market was valued at USD 35.24 billion in 2024 and is projected to grow to USD 39.69 billion in 2025, with a CAGR of 12.93%, reaching USD 73.12 billion by 2030.

In the rapidly evolving domain of proteomics, innovation and scientific breakthroughs are not just influencing research but also redefining how industries approach biological analysis. Over the recent years, the proteomics market has emerged as a cornerstone for advancements in medical research, agriculture, diagnostics, and drug discovery. This transformation is driven by a deeper understanding of protein functions and interactions that pave the way for precise therapeutic interventions and innovative product development. The current environment is vibrant and competitive, marked by the integration of multidisciplinary approaches and technology-driven discoveries. As stakeholders navigate this landscape, there is a rising emphasis on bridging the gap between traditional methodologies and novel techniques to extract deeper insights.

This executive summary presents a comprehensive exploration of the proteomics market, offering an in-depth view of emerging trends, technological advancements, and strategic insights that are crucial in shaping future growth. With an eye toward ensuring both a technical and business perspective, the discussion encapsulates market drivers, challenges, and opportunities. The overall narrative is designed to help leaders and decision-makers understand the transformative nature of proteomics, its strategic value proposition, and how investment in advanced research and equipment can fuel sustainable growth.

Transformative Shifts Reshaping Proteomics

The proteomics landscape is undergoing transformative shifts that are redefining industry paradigms and accelerating innovation. Modern breakthroughs are altering traditional research frameworks, catalyzing a transition from classical methods to advanced techniques that leverage automation, high throughput analysis, and integrated data systems. Technology advancements, particularly in mass spectrometry and advanced software analytics, have deepened the level of insights available, allowing researchers to decode complex protein interactions and pathways with unprecedented clarity.

Digital transformation and the incorporation of artificial intelligence have further elevated the capabilities of proteomics, enabling real-time analysis and predictive insights that drive accuracy and speed. These shifts are not isolated to laboratory research alone; they influence supply chain dynamics, product development cycles, and strategic investment decisions. Market participants are increasingly adopting specialized instruments and reagents, and aligning research investments with cutting-edge technological infrastructure to stay competitive in an ever-evolving global market. The merging of innovative research methods with efficient workflows has resulted in continuous improvements in reproducibility and cost efficiency. As the industry continues to grow, these transformative shifts are setting new benchmarks for quality, innovation, and scalability.

Furthermore, regulatory evolutions and heightened quality standards are compelling organizations to rethink long-standing practices. By integrating state-of-the-art analytical methodologies and cross-functional collaborations, companies are well-positioned to capitalize on emerging market demands and maintain a competitive edge.

Key Segmentation Insights in a Diversified Market

The comprehensive segmentation analysis reveals a multi-layered view of the proteomics market that underscores its complexity and breadth. Firstly, when examined based on type, the market is dissected into Expression Proteomics, Functional Proteomics, and Structural Proteomics, each offering nuanced insights into protein behavior and interactions. This classification allows stakeholders to tailor their approaches based on the specific protein functions and study requirements. In addition, a detailed examination of offerings spans Consumables, Instruments & Equipment, Reagents & Kits, Services, and Softwares, ensuring that every component essential to the proteomic workflow-from sample preparation and analysis to data interpretation-is thoroughly represented.

Moreover, the technological segmentation paints an intricate picture by categorizing the market into Chromatography, Electrophoresis, Mass Spectrometry, Protein Microarray, and X-Ray Crystallography. Within the realm of chromatography, further differentiation into Gas Chromatography and High-Performance Liquid Chromatography (HPLC) highlights the evolving methods in separation science. Similarly, electrophoresis is subdivided into capillary electrophoresis and gel electrophoresis, reflecting advancements in the precision and scalability of protein separation techniques. This multi-dimensional segmentation is further complemented by application-based studies which cover Agriculture & Food Safety, Biotechnology, Clinical Diagnostics, and Drug Discovery, thereby linking research to real-world industry applications.

Finally, segmentation by end-user offers keen insights into market demand across Academic Research Institutions, Contract Research Organizations, Hospitals & Diagnostic Labs, and Pharmaceuticals & Biotechnology Companies. This granular segmentation underscores the fact that the proteomics market is influenced by diverse needs and operational frameworks, enabling strategic decision-makers to customize solutions that align with their unique operational requirements and end-user expectations.

Based on Type, market is studied across Expression Proteomics, Functional Proteomics, and Structural Proteomics.

Based on Offering, market is studied across Consumables, Instruments & Equipment, Reagents & Kits, Services, and Softwares.

Based on Technology, market is studied across Chromatography, Electrophoresis, Mass Spectrometry, Protein Microarray, and X-Ray Crystallography. The Chromatography is further studied across Gas Chromatography and High-Performance Liquid Chromatography (HPLC). The Electrophoresis is further studied across Capillary electrophoresis and Gel electrophoresis.

Based on Application, market is studied across Agriculture & Food Safety, Biotechnology, Clinical Diagnostics, and Drug Discovery.

Based on End-User, market is studied across Academic Research Institutions, Contract Research Organizations, Hospitals & Diagnostic Labs, and Pharmaceuticals & Biotechnology Companies.

Key Regional Insights Reflecting Global Dynamics

A detailed regional analysis provides a panoramic view of the proteomics landscape across key markets worldwide. The Americas continue to be at the forefront, benefiting from robust research infrastructure and significant investment in biotechnological innovations. In parallel, the interlinked economies of Europe, the Middle East, and Africa are emerging as vital hubs, catalyzed by collaborative research initiatives and progressive funding schemes that are driving breakthroughs in both clinical and academic settings. Meanwhile, the Asia-Pacific region is witnessing accelerated growth in areas such as biotechnology and diagnostics, bolstered by government-backed research programs and increased capital inflows into bioscience sectors.

These diverse regional dynamics not only underline the varied market maturity levels but also stress how fiscal policies, research funding, and technological adoption can differ significantly across geographies. Each region serves as a unique case study reflecting specific strengths, challenges, and opportunities. Stakeholders are urged to consider these geographical nuances when developing global strategies and investment decisions. By acknowledging the distinct drivers of growth in the Americas, Europe, Middle East & Africa, and Asia-Pacific, decision-makers can better navigate the complex interplay between regional policies, market needs, and technological trends.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Comprehensive Insights on Leading Companies in Proteomics

The landscape is further enriched by an impressive roster of industry players who continually push the boundaries of proteomic science. Prominent organizations such as Agilent Technologies, Inc., Alphalyse A/S, Applied Biomics, Inc., and BGI Group contribute to setting technological benchmarks. Esteemed companies like Bio-Rad Laboratories, Inc., Biogenity ApS, and Biognosys AG have cemented their roles as pioneers in research and instrumentation excellence. Additionally, the innovation-driven efforts by Bruker Corporation, CD Genomics, and CovalX AG are reconfiguring how specialized equipment and advanced research services are deployed.

A further deep dive into the competitive dynamics reveals that Creative Proteomics, Danaher Corporation, and Eurofins EAG Materials Sciences LLC are shaping industry trends through extensive R&D investments and strategic collaborations. Emerging leaders including Evosep ApS and Illumina, Inc., along with notable contributions from JPT Peptide Technologies GmbH, Merck KGaA, and Meta Biosciences Pvt Ltd., are continuously advancing the field with disruptive technologies. Companies like Metware Biotechnology Inc., MS Bioworks LLC, and OmicScouts GmbH amplify the focus on scalable solutions and integrated research approaches. With major players such as PerkinElmer Inc., PolyQuant GmbH, Proteome Factory AG, Proteomics International Pty Ltd., Rapid Novor Inc., Thermo Fisher Scientific Inc, VProteomics, and Waters Corporation setting rigorous industry standards, the competitive landscape is as challenging as it is inspiring. Together, these companies drive a culture of innovation, ensuring a steady stream of advancements that pave the way for transformative applications in the proteomics sector.

The report delves into recent significant developments in the Proteomics Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alphalyse A/S, Applied Biomics, Inc., BGI Group, Bio-Rad Laboratories, Inc., Biogenity ApS, Biognosys AG, Bruker Corporation, CD Genomics, CovalX AG, Creative Proteomics, Danaher Corporation, Eurofins EAG Materials Sciences LLC, Evosep ApS, Illumina, Inc., JPT Peptide Technologies GmbH, Merck KGaA, Meta Biosciences Pvt Ltd., Metware Biotechnology Inc., MS Bioworks LLC, OmicScouts GmbH, PerkinElmer Inc., PolyQuant GmbH, Proteome Factory AG, Proteomics International Pty Ltd., Rapid Novor Inc., Thermo Fisher Scientific Inc, VProteomics, and Waters Corporation. Actionable Recommendations for Navigating the Evolving Proteomics Market

Industry leaders must prioritize strategic planning and versatile investments to thrive in the ever-changing proteomics market. It is crucial for organizations to continuously upgrade their research capabilities by embracing state-of-the-art instruments and technologies that enhance operational efficiency. Investing in new equipment and software that enables high-throughput analysis can significantly increase productivity, ensuring that the organization captures emerging trends swiftly and effectively. Leaders are encouraged to adopt a forward-thinking approach by integrating interdisciplinary collaboration and harnessing data analytics to forecast market directions and innovation pathways.

In addition, companies should strategically consider partnering with specialized vendors and research institutions to broaden their technological base and keep pace with rapid advancements. Emphasizing robust training programs and continuous learning can empower in-house teams to manage and optimize complex proteomics workflows. As the market evolves, businesses must remain agile, regularly revisiting their strategic plans in light of technological disruptions and regulatory changes. This adaptive approach not only ensures resilience in competitive landscapes but also fosters a culture that values innovative problem-solving and risk management.

Furthermore, resource allocation should not be confined solely to technology upgrades; equal emphasis must be placed on streamlining supply chains and enhancing service delivery models. Incorporating customer feedback and monitoring competitor strategies can lead to the development of refined products and services that set industry benchmarks. Lastly, leaders should maintain a clear focus on sustainability and ethical practices while driving technological exploration. By aligning innovative strategies with comprehensive market insights, industry players can build robust ecosystems that support long-term growth and excellence in the proteomics sector.

Conclusion: A Vision for Future Growth in Proteomics

The proteomics market stands at a pivotal juncture where technological prowess meets innovative research. This executive overview has illuminated the multifaceted growth drivers, segmentation intricacies, regional influences, and competitive dynamics that collectively define the prosperous landscape. It is evident that ongoing advancements in analytical instrumentation, coupled with dynamic data integration, are vigorously transforming traditional research methodologies. As market participants continue to blend academic insights with practical applications, the foundation for groundbreaking discoveries is becoming more solid and expansive.

Looking ahead, the convergence of biotechnology, electronics, and information technology is set to unlock new dimensions in proteomic research. Decision-makers are now tasked with strategically leveraging these insights to not only remain competitive but also to chart new trajectories in scientific exploration and innovation. The future of proteomics is imbued with promise, and organizations that adapt to emerging trends while remaining agile in their operations are most likely to reap significant long-term rewards. The synthesis of diverse market segments and the dedication to continuous improvement provide a roadmap for sustained growth and success in this vibrant field.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increased investment in drug discovery and biomarker research boosting proteomics
    • 5.1.1.2. Advancements in mass spectrometry and AI enhancing protein analysis precision
    • 5.1.1.3. Rising demand for personalized medicine driving proteomics market growth
  • 5.1.2. Restraints
    • 5.1.2.1. High costs and limited access to proteomics technologies in emerging markets
  • 5.1.3. Opportunities
    • 5.1.3.1. Expansion of proteomics applications in clinical diagnostics and precision healthcare
    • 5.1.3.2. Proteomics advancements in early disease detection and targeted therapies
  • 5.1.4. Challenges
    • 5.1.4.1. Navigating complex regulatory standards for proteomics technologies globally
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Structural proteomics provides detailed three-dimensional mappings of protein complexes and conformational structures
  • 5.2.2. Application: Ongoing drug discoveries boosting demand for proteomics across the globe
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Proteomics Market, by Type

• 6.1. Introduction
• 6.2. Expression Proteomics
• 6.3. Functional Proteomics
• 6.4. Structural Proteomics

7. Proteomics Market, by Offering

• 7.1. Introduction
• 7.2. Consumables
• 7.3. Instruments & Equipment
• 7.4. Reagents & Kits
• 7.5. Services
• 7.6. Softwares

8. Proteomics Market, by Technology

• 8.1. Introduction
• 8.2. Chromatography
  • 8.2.1. Gas Chromatography
  • 8.2.2. High-Performance Liquid Chromatography (HPLC)
• 8.3. Electrophoresis
  • 8.3.1. Capillary electrophoresis
  • 8.3.2. Gel electrophoresis
• 8.4. Mass Spectrometry
• 8.5. Protein Microarray
• 8.6. X-Ray Crystallography

9. Proteomics Market, by Application

• 9.1. Introduction
• 9.2. Agriculture & Food Safety
• 9.3. Biotechnology
• 9.4. Clinical Diagnostics
• 9.5. Drug Discovery

10. Proteomics Market, by End-User

• 10.1. Introduction
• 10.2. Academic Research Institutions
• 10.3. Contract Research Organizations
• 10.4. Hospitals & Diagnostic Labs
• 10.5. Pharmaceuticals & Biotechnology Companies

11. Americas Proteomics Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Proteomics Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Proteomics Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Illumina's groundbreaking pilot proteomics program aims to unlock disease insights with UK Biobank collaboration
  • 14.3.2. Bruker launched timsTOF Ultra 2, a state-of-the-art mass spectrometry device enhancing single-cell proteomics
  • 14.3.3. Biognosys and Alamar Biosciences partner to integrate NULISA assays and enhance DIA-MS platform
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Alphalyse A/S
• 3. Applied Biomics, Inc.
• 4. BGI Group
• 5. Bio-Rad Laboratories, Inc.
• 6. Biogenity ApS
• 7. Biognosys AG
• 8. Bruker Corporation
• 9. CD Genomics
• 10. CovalX AG
• 11. Creative Proteomics
• 12. Danaher Corporation
• 13. Eurofins EAG Materials Sciences LLC
• 14. Evosep ApS
• 15. Illumina, Inc.
• 16. JPT Peptide Technologies GmbH
• 17. Merck KGaA
• 18. Meta Biosciences Pvt Ltd.
• 19. Metware Biotechnology Inc.
• 20. MS Bioworks LLC
• 21. OmicScouts GmbH
• 22. PerkinElmer Inc.
• 23. PolyQuant GmbH
• 24. Proteome Factory AG
• 25. Proteomics International Pty Ltd.
• 26. Rapid Novor Inc.
• 27. Thermo Fisher Scientific Inc
• 28. VProteomics
• 29. Waters Corporation